Skip to main content

US FDA approves Gilead's COVID-19 drug for young children

The FDA has granted full approval to Gilead's remdesivir COVID-19 treatment for children 28 days and older.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.